Walley, Rosalind J.

Pharmaco-metabonomic phenotyping and personalized drug treatment

Andrew Clayton, T., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J.-P., Le Net, J.-L., Baker, D., Walley, R. J., et al. (2006) · Nature

Pharmacogenetics and Drug MetabolismMetabolomics and Mass Spectrometry Studies

Cited by 824

Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy

Scheele, W., Diamond, S., Gale, J., Clerin, V., Tamimi, N., Le, V., Walley, R., Grover-Páez, F., Perros-Huguet, C., Rolph, T., et al. (2016) · Journal of the American Society of Nephrology

Chronic Kidney Disease and DiabetesPhosphodiesterase function and regulation

Cited by 65

The translational challenge in the development of new and effective therapies for endometriosis: a review of confidence from published preclinical efficacy studies

Pullen, N., Birch, C. L., Douglas, G. J., Hussain, Q., Pruimboom-Brees, I., & Walley, R. J. (2011) · Human Reproduction Update

Endometriosis Research and TreatmentAnimal testing and alternatives

Cited by 42